A limitation of our study may be the decision to measure CRP at diagnosis, which may have obscured the contribution from obesity, as inflammation within the primary tumour may have been the main contributor to high serum CRP. The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.